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Myopia, currently at epidemic levels in East Asia, is a leading cause of untreatable visual impairment. 
Genome-wide association studies (GWAS) in adults have identified 39 loci associated with refractive 
error and myopia. Here, the age-of-onset of association between genetic variants at these 39 loci and 
refractive error was investigated in 5200 children assessed longitudinally across ages 7–15 years, along 
with gene-environment interactions involving the major environmental risk-factors, nearwork and 
time outdoors. Specific variants could be categorized as showing evidence of: (a) early-onset effects 
remaining stable through childhood, (b) early-onset effects that progressed further with increasing age, 
or (c) onset later in childhood (N = 10, 5 and 11 variants, respectively). A genetic risk score (GRS) for 
all 39 variants explained 0.6% (P = 6.6E–08) and 2.3% (P = 6.9E–21) of the variance in refractive error 
at ages 7 and 15, respectively, supporting increased effects from these genetic variants at older ages. 
Replication in multi-ancestry samples (combined N = 5599) yielded evidence of childhood onset for 6 of 
12 variants present in both Asians and Europeans. There was no indication that variant or GRS effects 
altered depending on time outdoors, however 5 variants showed nominal evidence of interactions with 
nearwork (top variant, rs7829127 in ZMAT4; P = 6.3E–04).
The refractive errors myopia and hyperopia are common visual disorders that typically require correction with 
spectacles, contact lenses, or refractive eye surgery. Myopia – particularly with increasing severity – is a leading 
cause of irreversible visual impairment and blindness due primarily to stretching and thinning of the ocular 
tissues within the posterior segment of the eye. These changes are associated with an increased risk of retinal 
detachment, chorioretinal atrophy, choroidal neovascularisation, myopic maculopathy, glaucoma and cataract1,2. 
Myopia is rare in infancy, usually developing during school age or in early adulthood3. For current generations 
of young adults, approximately 30–40% of individuals in Western countries4,5 and 80% of those in urban areas of 
East Asia6,7 have myopia.
Genome-wide association studies (GWAS) in primarily population-based samples8–14 and next-generation 
sequencing (NGS) studies of carefully selected high myopia pedigrees harbouring extremely rare, high pene-
trance disease-causing mutations15–20 have improved our understanding of the genetics of refractive error and 
myopia. To date at least 39 distinct loci harbouring common genetic variants showing genome-wide significant 
association with refractive error have been identified through GWAS. For the genetic variants that contribute 
most to the burden of myopia in the general population (i.e. the GWAS-identified variants) it is not yet known 
whether the variants act during very early life, childhood, or in adulthood. This is an important question given 
that knowledge of the time and mode of action of the causal variants at the associated loci is necessary for detect-
ing children at-risk of myopia (who would benefit most from treatment intervention), and would aid the design 
of new therapies capable of halting myopia progression.
For environmental risk factors to which most children are exposed, inter-individual differences in genetic sus-
ceptibility may account for some of the phenotypic variance21. Exposure to nearwork, i.e. reading and other tasks 
requiring prolonged near vision, has long been proposed as an environmental risk factor for myopia to which 
children are ubiquitously exposed during their schooling. The total duration of reading, the period of continuous 
reading, the reading distance between the text and the eyes, and variation in nearwork exposure outside of the 
school day have each been shown to be associated with refractive error or myopia progression22,23. The other most 
strongly implicated environmental risk factor for myopia is insufficient time spent outdoors24–26, and it has been 
suggested that time spent outdoors and time spent performing nearwork activities together underlie the robust 
association between myopia and educational achievement2,27. Gene-environment (GxE) interactions – which in 
this project we define as marker-phenotype associations whose effects differ statistically depending on whether 
individuals have been exposed to a high vs. low level of an environmental risk factor – may contribute extensively 
to variation in disease susceptibility28. Given the recent identification of gene-environment interactions involving 
nearwork or level of education, a key question in myopia research currently is whether GxE interactions contrib-
ute to the rising prevalence of myopia and to the higher incidence rate observed in young Asian populations as 
compared to their European counterparts.
We carried out analyses of pediatric/adolescent cohorts collaborating in the Consortium for Refractive 
Error And Myopia (CREAM) to investigate whether the top index variants at the 39 loci previously identified in 
GWAS meta-analyses of adults have early-onset effects manifest during childhood. We also tested for evidence 
of GxE interactions involving either nearwork or time spent outdoors. A single large cohort with longitudinal 
measurements of refractive error over much of childhood was used for the primary analyses. Meta-analyses of 
cross-sectional samples were then used to test for replication.
Methods
Participants and phenotypes. All participants were aged < 25 years-old and none had been included in 
the earlier CREAM meta-analysis of refractive error9, which only included individuals > 25 years of age. Details 
of the participant recruitment and phenotypic assessment are presented in the Supplementary Information. The 
study was conducted in accordance with the Declaration of Helsinki, and all participants provided informed con-
sent. The experimental protocols for the study were approved by the respective ethical review boards at host insti-
tutions, as follows. ALSPAC, the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees; 
BATS, the Human Research Ethics Committee at the QIMR Berghofer Medical Research Institute; GZT, the 
Ethics Review Board of the Zhongshan Ophthalmic Center of Sun Yat-Sen University; RAINE, the Human 
Research Ethics Committee at the University of Western Australia; SCORM and STARS, the Institutional Review 
Boards of the Singapore Eye Research Institute, Singapore General Hospital, National University of Singapore, 
and the National Healthcare Group, Singapore; TEDS, the Institute of Psychiatry ethics committee; TEST, the 
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Royal Victorian Eye and Ear Hospital, the University of Tasmania, and the Australian Twin Registry; WESDR, the 
Health Sciences Institution Review Board of the University of Wisconsin, Madison.
Participants underwent cycloplegic autorefraction (RAINE, TEST, BATS, GZT, SCORM, STARS) or 
non-cycloplegic autorefraction (ALSPAC) or subjective refraction (TEDS, WESDR) and the spherical equivalent 
refractive error averaged between the two eyes was calculated. Parental questionnaires that included items on 
time spent engaged in nearwork outside of school, and time spent in outdoor activities were used to classify chil-
dren as spending a high or low amount of time performing nearwork (Table S6) or outdoors (Table S7) each day. 
Classification was done within each cohort separately, using a median split (“low” group, exposure below median 
level; “high” group, exposure above median level).
Genetic analysis. DNA samples obtained from blood or saliva were genotyped using either an Illumina or 
Affymetrix high-density single nucleotide polymorphism (SNP) array, and genotypes at untyped markers were 
imputed using the 1000-Genomes Project reference panel (see Table S5 for details). Stringent quality control 
procedures (e.g. imputation quality r2 or info score > 0.5) were applied to each cohort separately (Supplementary 
Information). 39 SNPs that showed genome-wide significant association with refractive error in the general adult 
population in two previous GWAS analyses8,9 were selected for evaluation (Table S1).
Cross-sectional models and meta-analyses. For each of the 8 cross-sectional cohorts separately, single 
SNP tests of association with refractive error were conducted using the following linear regression model:
β β β ε= + + + +y m a s g (1)i i Age i Sex i SNP i
where yi is the spherical equivalent refractive error of the ith participant, of age ai and sex si and with gi their risk 
allele dosage on the scale 0–2 for the test SNP, and εi the residual. Regression coefficients are indicated as βAge, βSex, 
and βSNP for the model parameters age, sex and SNP genotype, respectively. Additional G x E interaction models 
were tested for samples with information available on environmental exposures, nearwork or time outdoors (both 
exposures coded: 0 = low, 1 = high). For the ith participant, using ni to denote nearwork and ti for time outdoors:
β β β β β ε= + + + + + +⋅y m a s g n g n (2)i i Age i sex i SNP i NW i i SNP NW i
β β β β β ε= + + + + + +⋅y m a s g t g t (3)i i Age i sex i SNP i TO i i SNP TO i
Results from the individual cohorts were meta-analyzed in 5599 individuals comprising 5 cohorts of European 
ancestry (BATS, RAINE, TEDS, TEST, WESDR; N = 3,143; Table 1) and 3 cohorts of Asian ancestry (GZT, 
SCORM, STARS; N = 2,456; Table 1) using a weighted inverse-variance, fixed effects model29. A random effects 
model was used if Cochran’s Q-test for heterogeneity yielded a P-value below 0.05.
Longitudinal study (ALSPAC). Refractive error was included in the clinical assessments for ages 7, 10, 11, 
12 and 15 years in ALSPAC children30. Linear mixed models for refractive trajectory were fit as described30 using 
the nlme package in R31 for individuals (N = 5,200; Table 1) who underwent at least 3 refractive assessments and 
whose genotype data passed quality control filters (as described in the Supplementary Information). Briefly, SNP 
dosage, age and higher-order age terms (age2 and age3) were modelled as fixed effects while for each child, the dif-
ference from the average refractive error at baseline and the linear rate of change in refractive error were modelled 
as individual-level random effects, using an autoregressive correlation structure. To examine GxE interactions, 
initially, 3-way interaction models were tested that included the interaction between SNP, change-from-baseline 
in age, and environmental exposures (nearwork or time outdoors). If the P-value for the 3-way interaction was 
>0.05 then models including only 2-way interactions were tested.
Quanto32 was used to gauge the power to detect main and interaction effects in the ALSPAC cohort. These cal-
culations assumed a minor allele frequency (MAF) of 0.25, a sample size of 4461 (corresponding to 5,200 minus 
Longitudinal cohort (N = 5,200)
Study Ethnicity N Female (%) Age-at-baseline Years follow-up
 ALSPAC* European 5200 51.0 7.5 (0.3) 7.0 (1.5)
Cross-sectional cohorts (N = 5,599)
Study Ethnicity N Female (%) Age (years) Refraction (D)
 TEDS European 698 56.0 16.2 (1.8) − 0.38 (1.70)
 WESDR European 289 50.5 17.7 (4.6) − 1.09 (1.79)
 TEST European 410 57.2 11.8 (5.0) 0.36 (1.24)
 RAINE European 754 50.9 20.0 (0.4) − 0.06 (1.53)
 BATS European 992 53.6 19.1 (3.2) − 0.33 (1.42)
 GZT Asian 1055 51.8 15.6 (2.8) − 1.97 (2.49)
 SCORM Asian 994 48.4 7.5 (0.9) − 0.55 (1.73)
 STARS Asian 407 49.4 6.6 (3.9) − 2.00 (2.09)
Table 1.  Demographics of study samples. Values in brackets are standard deviations. *Refraction details at 
each age for the longitudinal cohort are provided in the supplementary material (Table S8).
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739 participants with missing information about time spent performing nearwork), a binary exposure affecting 
39% of the cohort (equivalent to that for high vs. low nearwork exposure in ALSPAC) and a refractive error distri-
bution with a mean of zero and a standard deviation of 1.50 D. The estimated power would be conservative given 
that a linear mixed model analysis will have greater power than a linear model analysis.
Genetic risk score for all 39 SNPs. A genetic risk score was computed by summing the dosage of risk 
alleles for all 39 SNPs. In individuals of Asian ancestry only 31 of the 39 SNPs were polymorphic (MAF > 0.05) 
and therefore contributed to the genetic risk score calculation. The frequency distribution of genetic risk score in 
each sample was normally distributed with a mean of 36 (95% C.I. 29 to 42) alleles in Europeans and 40 (95% C.I. 
37 to 42) alleles in Asians. To calculate the variance in refractive error explained by the genetic risk score at a spe-
cific age for participants in the ALSPAC cohort, refractive error at age 7.5 years (or at age 15 years) was regressed 
on genetic risk score using a linear model. The covariates age and sex were not associated with refractive error 
when included in the age 7.5 or the age 15 year model, and their inclusion did not improve the fit of either model 
(note that being a birth cohort, the age range was narrow). Hence these covariates were omitted. The variance 
explained by the genetic risk score was therefore taken as the R2 value for a model that included the genetic risk 
score as the only predictor variable.
Pathway analysis. The genes (Table 2) implicated in having early-onset effects (N = 10 genes) or later-onset 
effects (N = 11 genes) in the ALSPAC discovery sample were evaluated using PANTHER Version 10.0 (release 
date May 15, 2015)33 and DAVID Version 6.7 (release date 27 Jan, 2010)34 to identify potential functional 
pathways.
Results
Early-onset and later-onset effects in childhood. Nine cohorts of children/adolescents were studied 
(Table 1). The largest of these, ALSPAC (N = 5,200), which had longitudinal data for refractive error, was used for 
discovery analyses, and 8 cross-sectional cohorts were used for validation. The discovery cohort had ~80% power 
to detect an association for a SNP with an effect size of 0.1 D and MAF of 0.25.
Of the 39 SNPs examined, 16 showed evidence of onset in childhood (Table 2 and Table S2). Early-onset asso-
ciations already manifest at 7.5 years of age were present for 10 SNPs (P = 4.8E–02 to P = 5.3E–03). Later-onset 
associations that emerged between the ages of 7.5 and 15 were noted for 11 SNPs (P = 4.9E–02 to 8.8E–04 for SNP 
x Age interaction). Five SNPs showed a main effect at baseline as well as later progressive effects. Examples of 
SNPs showing evidence of early-onset and later-onset effects are presented in Fig. 1 for early-onset CHRNG SNP 
rs1881492, later-onset A2BP1 (also known as RBFOX1) rs17648524, and PRSS56 rs1656404 with both effects. For 
all associated SNPs the “direction of effect” was the same as in the original GWAS8,9.
The genetic risk score was very strongly associated with refractive error both at 7.5 years of age (β = − 0.018 D, 
95% CI − 0.012 to − 0.024, P = 2.2E–9) and with increasing age (β = − 0.003 D/yr, 95% CI − 0.002 to − 0.004, 
P = 5.8E–14). By the age of 15 years, the model suggested that the 39 SNPs together would produce a more 
than 1.0 D difference in refractive error between participants carrying the lowest and highest number of risk 
SNP main effect at baseline (D) SNP x Age interaction (D/yr)
Marker Chr Gene RA RAF Beta SE P Beta SE P
GR Score – – – – −0.018 0.003 2.2E–09 −0.003 0.000 5.8E–14
rs1652333 1 CD55 G 0.32 − 0.002 0.019 9.3E–01 −0.005 0.003 4.0E–02
rs1656404 2 PRSS56 A 0.21 −0.066 0.024 5.7E–03 −0.008 0.003 1.3E–02
rs1881492 2 CHRNG T 0.23 −0.058 0.024 1.7E–02 − 0.005 0.003 1.5E–01
rs14165 3 CACNA1D G 0.70 −0.040 0.020 4.2E–02 − 0.001 0.003 7.7E–01
rs7744813 6 KCNQ5 A 0.59 −0.048 0.019 9.9E–03 −0.005 0.003 3.5E–02
rs12205363 6 LAMA2 T 0.92 −0.097 0.035 5.7E–03 − 0.008 0.005 1.2E–01
rs7837791 8 TOX G 0.53 −0.045 0.018 1.1E–02 −0.005 0.002 2.7E–02
rs4237036 8 CHD7 T 0.66 0.020 0.019 2.9E–01 −0.007 0.003 5.6E–03
rs7042950 9 RORB G 0.22 0.018 0.022 4.1E–01 −0.009 0.003 2.5E–03
rs6480859 10 KCNMA1 T 0.37 − 0.029 0.018 1.1E–01 −0.008 0.002 1.3E–03
rs10882165 10 CYP26A1 T 0.40 −0.035 0.018 4.8E–02 0.001 0.003 7.6E–01
rs8000973 13 ZIC2 C 0.52 −0.042 0.018 1.8E–02 −0.008 0.002 1.5E–03
rs66913363 14 BMP4 G 0.51 −0.051 0.018 5.3E–03 0.001 0.003 7.2E–01
rs524952 15 GJD2 A 0.46 − 0.018 0.018 3.3E–01 −0.008 0.003 8.8E–04
rs17648524 16 A2BP1 C 0.33 − 0.001 0.019 9.4E–01 −0.007 0.003 5.6E–03
rs2969180 17 SHISA6 A 0.35 −0.039 0.019 3.9E–02 −0.005 0.003 4.9E–02
Table 2.  Age-of-onset of SNP associations with refractive error in the discovery cohort (ALSPAC). 
Abbreviations: Chr = Chromosome. GR = Genetic risk. RA = Risk allele. RAF = Risk allele frequency. 
Associations were tested at baseline (age of 7.5 years-old) and over the next 7 years (SNP x Age interaction). 
Results for all 39 SNPs are shown in Table S2.
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alleles observed (Fig. 2). At age 7.5 years the genetic risk score explained 0.6% of the variation in refractive error 
(N = 4,566; P = 6.6E–08); at age 15 years the corresponding figure was 2.3% (N = 3,666; P = 6.9E–21).
For validation we tested the genetic risk score and 12 of the 16 above SNPs (4 were nearly monomorphic in 
Asians) in the 8 multi-ethnic cross-sectional study cohorts (combined N = 5,599; Table 1). The average age of the 
participants varied from 6.6 years-old in the STARS cohort to 20.0 years-old in RAINE. The genetic risk score 
and 4 SNPs – rs7744813 (KCNQ5), rs7837791 (TOX), rs8000973 (ZIC2) and rs17648524 (A2BP1) – were associ-
ated with refractive error (P < 0.05; Table 3). All 4 SNPs had the expected direction of effect and none exhibited 
evidence of between-cohort heterogeneity. Interestingly, 3 of the 4 SNPs had evidence of both early-onset and 
later progressive effects in the discovery cohort. Meta-analysis summary plots for the genetic risk score and the 
individual SNPs tested for replication are presented in Figure S1. There was suggestive evidence that SNPs had 
larger effect sizes in Asian than in European ancestry participants (Figure S2).
Figure 1. SNPs associated with early-onset and later-onset effects on refractive development during 
childhood. Analyses were carried out using data from longitudinal eye examinations in 5,200 ALSPAC 
participants. Each panel shows how refractive error trajectory varied with SNP genotype, for 4 different 
SNPs: rs1881492, rs17648524, rs1656404 and rs2155413. The lines in each panel show the refractive error 
trajectories predicted by the best-fit linear mixed model (LMM) for participants carrying the number of risk 
alleles indicated (0, 1 or 2). The SNPs in panels (a,c) showed an association with refractive error at baseline, 
i.e. evidence of early onset in childhood. The SNPs in panels (b,c) showed an age-dependent interaction with 
refractive error over later childhood. The SNP in panel (d) did not show evidence of effects during childhood.
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Tests in the Discovery Cohort for SNP x SNP interactions for all 741 possible pairs of the 39 SNPs revealed no 
evidence for interactions exceeding that expected by chance (not shown).
Interactions with time engaged in nearwork. Two types of interactions between SNP genotype and 
nearwork exposure were evaluated in the ALSPAC discovery cohort: An interaction already present at the base-
line age of 7.5 years-old (a 2-way SNP x nearwork interaction) and an interaction that developed progressively 
during later childhood (a 3-way, SNP x nearwork x age-from-baseline interaction). For a SNP with a risk allele 
frequency of 0.25, and ignoring the repeated measures nature of the data, the analysis of ALSPAC participants had 
> 90% power to detect an interaction effect of 0.25 D at α = 0.05 (and > 50% power at α = 1.28E–3, corresponding 
to a Bonferroni correction for testing all 39 SNPs).
Nominal support for 3-way SNP x nearwork x age-from-baseline interactions was observed for 4 markers 
(Fig. 3a–d): rs17428076 upstream of DLX1 (P = 0.049), rs7829127 within ZMAT4 (P = 6.3E–04), rs7084402 
upstream of BICC1 (P = 0.043) and rs17648524 within A2BP1 (P = 2.3E–03). In models that considered just 
2-way interactions at baseline, only rs1254319 upstream of SIX6 showed nominal evidence of an interaction 
(P = 0.042; Fig. 3e). Of these 5 interactions, only that involving rs7829127 (ZMAT4) survived correction for mul-
tiple testing (corrected P = 0.025). Consistent with the limited evidence for individual SNP x nearwork interac-
tions, no evidence of interaction between the genetic risk score and ALSPAC children’s level of nearwork was 
observed (2-way interaction, P = 0.20; 3-way interaction, P = 0.086).
Four of the cross-sectional study cohorts, 1 of European ancestry (TEDS) and 3 of Asian ancestry (GZT, 
SCORM and STARS), had information available regarding the time participants spent engaged in nearwork 
(Table S6), allowing tests for replication. In the meta-analysis of all 4 replication studies (Table S3) none of the 
SNPs that showed nominal evidence of an interaction with nearwork in the ALSPAC discovery cohort showed 
evidence of replication (all P > 0.16). Likewise, the genetic risk score did not show evidence of an interaction with 
nearwork in the cross-sectional cohorts (P = 0.49).
Interactions with time spent outdoors. In the discovery cohort, only rs13091182 within ZBTB38 
showed nominal evidence of a 3-way interaction involving time outdoors (uncorrected P = 0.028; corrected 
P > 0.05; Fig. 3f). Surprisingly, the risk allele of rs13091182 was associated with slower progression towards myo-
pia (or less hyperopia) in general and with faster progression towards myopia in children who spent more time 
outdoors, suggesting a potentially false-positive result. There was no evidence for 2-way SNP x time outdoors 
interactions (uncorrected P > 0.20 for all 39 SNPs). Similarly, for the genetic risk score, there was no indication of 
an interaction with time spent outdoors (2-way interaction, P = 0.16; 3-way interaction, P = 0.49).
Five of the cross-sectional samples had information available on the time participants spent outdoors (TEDS, 
RAINE, GZT, SCORM and STARS). The single SNP, rs13091182, showing evidence of an interaction with 
time outdoors in the discovery cohort showed no evidence of replication (indeed, none of the 31 SNPs with 
Figure 2. Association between a genetic risk score for 39 SNPs and refractive error trajectories in ALSPAC 
participants. The genetic risk score was calculated as the sum of the number of risk alleles (0–2) carried by an 
individual at each of the 39 myopia-susceptibility SNPs. The coloured lines show the trajectories for children 
carrying the number of risk alleles indicated, as predicted by the best-fit linear mixed model.
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MAF > 0.05 in both ancestry groups showed evidence of an interaction with time outdoors; all P > 0.17; Table S4). 
Similarly, the genetic risk score did not show evidence of an interaction with time spent outdoors in the replica-
tion cohorts.
Pathway analysis. Pathway analysis identified a single functional pathway for the set of 10 genes (Table 2) 
implicated in having early-onset effects, namely “hedgehog signalling” (Panther P = 0.043; key genes ZIC2 and 
BMP4). The set of 11 genes implicated in having later-onset effects did not show enrichment for specific pathways.
Discussion
Early-onset and later-onset SNP effects. Sixteen SNPs showed evidence of effects in childhood in 
ALSPAC participants (Table 2); 10 SNPs had early-onset effects manifest by age 7.5 years, 11 SNPs had later-onset 
effects, and 5 SNP had early-onset effects that progressed further during later childhood. For the 12 of these 16 
SNPs available in the cross-sectional cohorts, 4 showed evidence of replication (Table 3). There was suggestive 
evidence that SNP effect sizes were approximately 2 times larger in Asian as compared to European ancestry 
children/adolescents (Figure S2). A genetic risk score that captured the effects of all 39 GWAS-identified variants 
confirmed the involvement of genetic influences acting at an early age (7.5 years) and then increasing further in 
magnitude across later childhood.
We sought to discover whether the early-onset and later-onset variants clustered according to functional path-
way (for example, if GWAS SNPs A and B are causal variants that affect the expression levels of genes X and Y, 
respectively, and X acts downstream of Y to regulate refractive development, then one might expect the onset 
age for SNPs A and B to coincide). However, as summarised in Table 4, SNPs associated with early-onset or 
later-onset effects did not clearly cluster according to the known function(s) of the genes implicated in mediat-
ing the SNPs’ effects. Pathway analysis confirmed this impression, with only a single functional pathway being 
identified. Potential reasons for this lack of functional clustering are, first, that many genes in the genome have 
diverse functions, which are sometimes poorly understood. For instance, during development of the human 
visual system, an ion channel may play a vital role during early embryonic development of the retina, be a neces-
sary component of the visual cycle, and yet also contribute to neuronal plasticity. Second, precisely which gene or 
genes mediate the effect of a specific GWAS-identified SNP is not known with certainty for any of the refractive 
error GWAS SNPs identified to date: While the nearest gene to a GWAS SNP is usually considered the most likely 
to be involved, this does not always hold true35.
The 39 SNPs examined were identified in adult GWAS meta-analyses with sample sizes of approximately 
45,000 individuals, and all had small effects (typically 0.1 D per copy of the risk allele). The ALSPAC longitudinal 
cohort (N = 5,200) had ~80% power to detect an association for a SNP with an effect size of 0.1 D and MAF of 
0.25 (but note that the true power would likely have been lower because: refractive development would not be 
complete by 15 years of age, our models tested primarily for yearly effects rather than cumulative effects, and 
the “winner’s curse” phenomenon36, i.e. the over-estimation of effect sizes in the original GWAS investigations). 
Therefore, a likely reason why some of the 39 SNPs we studied failed to show childhood-onset associations in the 
longitudinal cohort is limited statistical power. Thus, we cannot conclude that the SNPs that did not show observ-
able childhood-onset associations have an age-of-onset beyond 15 years-old even though they might well do: 
much larger studies will be required to definitively address this issue. Similarly, the limited concordance between 
the longitudinal and cross-sectional studies was also likely due to limited statistical power, although 8 of the 12 
SNPs tested for replication showed the expected direction of effect (Table 3).
Europeans (N = 3,143) Asians (N = 2,456) Europeans + Asians (N = 5,599)
Marker Chr Gene RA RAF Beta SE P RAF* Beta SE P I2 Het_P Beta SE P
GR Score – – – – −0.026 0.007 3.8E–04 – −0.048 0.011 1.4E–05 0.57 0.023 − 0.034 0.006 1.4E–08
rs1652333 1 CD55 G 0.32 0.042 0.042 0.315 0.52 –0.101 0.056 0.073 0.27 0.210 − 0.004 0.034 0.899
rs1881492 2 CHRNG T 0.23 − 0.001 0.054 0.986 0.12 0.197 0.102 0.054 0.00 0.926 0.033 0.048 0.483
rs7744813 6 KCNQ5 A 0.59 − 0.110 0.042 0.008 0.81 0.001 0.071 0.993 0.41 0.107 − 0.083 0.036 0.021
rs7837791 8 TOX G 0.53 0.011 0.040 0.772 0.53 − 0.185 0.055 0.001 0.49 0.059 − 0.063 0.032 0.049
rs4237036 8 CHD7 T 0.66 − 0.077 0.041 0.062 0.74 0.102 0.069 0.140 0.40 0.112 − 0.033 0.035 0.358
rs7042950 9 RORB G 0.22 0.041 0.047 0.391 0.74 − 0.004 0.070 0.956 0.00 0.903 0.020 0.039 0.618
rs6480859 10 KCNMA1 T 0.37 − 0.022 0.041 0.579 0.16 − 0.229 0.074 0.002 0.52 0.042 − 0.063 0.036 0.075
rs8000973 13 ZIC2 C 0.52 − 0.067 0.040 0.093 0.21 − 0.092 0.070 0.190 0.00 0.470 − 0.081 0.035 0.019
rs66913363 14 BMP4 G 0.51 − 0.021 0.044 0.628 0.73 0.061 0.066 0.354 0.00 0.790 0.002 0.037 0.953
rs524952 15 GJD2 A 0.46 − 0.008 0.041 0.839 0.48 − 0.171 0.057 0.003 0.53 0.036 − 0.064 0.033 0.058
rs17648524 16 A2BP1 C 0.33 − 0.143 0.042 7.2E–04 0.06 − 0.140 0.106 0.186 0.49 0.057 − 0.146 0.039 2.0E–04
rs2969180 17 SHISA6 A 0.35 0.028 0.042 0.499 0.51 − 0.036 0.056 0.521 0.00 0.553 0.003 0.033 0.926
Table 3.  Replication meta-analysis results for SNP main effects. SNPs associated with refractive error in 
the ALSPAC age-of-onset analyses were tested for association with refractive error in 8 independent cohorts 
of children (5 European ancestry, 3 Asian ancestry). Abbreviations: Chr = Chromosome. GR Score = Genetic 
risk score. RA = Risk allele. RAF = Risk allele frequency. *SNPs with minor allele frequencies < 0.05 were not 
examined due to low statistical power.
www.nature.com/scientificreports/
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Figure 3. Refractive error trajectories in ALSPAC participants for SNPs showing evidence of an interaction 
with nearwork or time outdoors. Levels of nearwork activity and time spent outdoors were assessed at 8–9 
years of age and classified as high or low (above or below the median level). Panels (a–d) show how refractive 
error trajectories varied depending on nearwork level and the number of risk alleles (0–2) carried for 4 different 
markers that showed SNP x nearwork x age-from-baseline (3-way) interactions. Panel (e) Refractive trajectories 
for the only marker to show a SNP x nearwork (2-way) interaction at baseline age. Panel (f ) Refractive 
trajectories for the only marker to show a SNP x time outdoors x age-from-baseline (3-way) interaction. The 
coloured lines show the trajectories predicted by the best-fit linear mixed model for children carrying the 
number of copies of the risk allele indicated in the legend.
www.nature.com/scientificreports/
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Interactions with environmental exposures. In general there was scant evidence for GxE interactions, 
especially for SNP x time spent outdoors effects. Given the expected power of > 90% to detect interaction effects 
with a magnitude 0.25 D or more, this argues against SNP x nearwork or SNP x time outdoors interactions of 
this size being present for the majority of variants studied, rather than lack of statistical power precluding their 
discovery.
In the ALSPAC longitudinal analysis the gene-environment interaction between ZMAT4 SNP rs7829127 gen-
otype and nearwork survived correction for multiple-testing (Pcorr = 0.025). Although this interaction was not 
replicated in the cross-sectional meta-analyses, variants at this locus have previously been reported to show an 
interaction with the duration of education in a meta-analysis of 5 studies from Singapore (SNP x education 
interaction = − 0.42 D, 95% C.I. − 0.15 to − 0.69, P = 0.002)37. We did not explore interactions between SNPs and 
years of education, since in several cohorts the participants were still students. The functional role of ZMAT4 is 
not known.
Why might GxE interactions involving these 39 SNPs be so scarce? First, differences in environmental risk 
exposures were not considered in the original GWAS investigations carried out by CREAM9 and 23andMe8. 
Thus, SNPs with strong interaction effects but no main effects may not have been detected using those GWAS 
designs. Second, the age range and ethnic diversity of the original GWAS discovery samples were highly varied. 
Given the substantial increase in the prevalence of myopia in the past few decades, which strongly implicates a 
major role for environmental risk factors, it seems almost certain that the individuals studied in the CREAM and 
23andMe GWAS meta-analyses would have grown up in environments with a wide range of risk exposure profiles 
depending on the participants’ years of birth: young (recently born) individuals would have been exposed to a 
much more myopiagenic environment than older (more distantly born) adults. Therefore, a variant that increases 
the risk of myopia only in children who perform excessive nearwork may have shown an (apparent) main effect 
association with refractive error in a GWAS carried out in a young adult cohort, in which participants were ubiq-
uitously exposed to high nearwork during childhood. However, this same variant may not have shown an associ-
ation with refractive error in a GWAS on an older cohort, due to the lower nearwork exposure during childhood 
of the older individuals. Thus, support for the association of such a variant in the CREAM and 23andMe GWAS 
samples may have been diluted rather than strengthened during the meta-analysis of younger and older cohorts.
Separate from tests for gene-environment interactions, time spent outdoors itself was not associated with 
myopia in 3 of the 5 cross-sectional studies (GZT, STARS, and TEDS) and the association was of borderline sig-
nificance in another (TEDS). This lack of an association with time outdoors implies that detecting a SNP x time 
outdoors interaction would also have been challenging, even after meta-analysis of data from all 5 cohorts.
Interestingly, a large-effect GxE interaction predisoposing children to myopia was identified recently, 
involving a rare variant at the APLP2 gene locus and time spent reading38. APLP2 was implicated in myopia 
SNP Gene Role
Longitudinal Early-
onset
Longitudinal Later-
onset Cross-sectional Interaction
GR score – – Y Y Y
rs7837791 TOX ED Y Y Y
rs4237036 CHD7 ED Y
rs7084402 BICC1 ED NW
rs8000973 ZIC2 ED Y Y Y
rs66913363 BMP4 ED Y
rs1254319 SIX6 ED NW
rs1656404 PRSS56 ED, EM Y Y
rs17428076 DLX1 ED,NP NW
rs12205363 LAMA2 EM Y
rs1652333 CD55 IT Y
rs1881492 CHRNG IT Y
rs14165 CACNA1D IT Y
rs6480859 KCNMA1 IT Y
rs7744813 KCNQ5 IT, VC Y Y Y
rs17648524 A2BP1 NP Y Y NW
rs13091182 ZBTB38 U TO
rs9307551 LOC100506035 U NW
rs7829127 ZMAT4 U NW
rs2969180 SHISA6 U Y Y
rs7042950 RORB VC Y
rs10882165 CYP26A1 VC Y
rs524952 GJD2 VC Y
Table 4.  Summary of findings. SNPs with evidence (P < 0.05) of early-onset, later onset, or GxE interaction 
effects on refractive error in one or more analysis are highlighted. Abbreviations: Y = Yes, NW = Nearwork, 
TO = Time outdoors, VC = Visual cycle, NP = Neuronal plasticity, IT = Ion transport, EM = Extracellular 
matrix, ED = Eye development, U = Unknown.
www.nature.com/scientificreports/
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development through studies in an animal model39, which – given the statistical challenge of identifying GxE 
interaction effects in human populations – suggests that combining findings from animal models and human 
studies could be a fruitful future approach.
We reasoned that correction for multiple testing was not appropriate when examining the age-of-onset of the 
39 SNPs investigated, because of compelling existing evidence that by adulthood these SNPs truly are associated 
with refractive error. That is, our analyses sought to discover whether or not each SNP had an effect during child-
hood, not whether a group of candidate SNPs were associated with refractive error per se. By contrast, in view of 
very limited evidence for interactions with environmental exposures for most of the SNPs examined, correction 
for multiple testing was considered appropriate when evaluating SNP x nearwork and SNP x time outdoors inter-
actions: In these analyses, a large number of independent hypothesis tests were carried out, with little or no prior 
knowledge that an interaction must be present at some age.
Limitations of the present work. The present work had a number of other limitations. The cross-sectional 
samples were not matched for age, which prevented us from testing for “early” and “later” onset effects in the rep-
lication stage. The level of exposure to nearwork and time outdoors also varied across samples, which meant that 
imprecisely-matched interaction effects were meta-analysed, potentially reducing statistical power. We chose to 
categorise time spent performing nearwork and time spent outdoors relative to the median activity level in each 
study sample because the measurement scales used in the various studies were not standardised (precluding the 
use of an absolute measure). If in reality these environmental risk factors exert their influence non-linearly – for 
instance if spending more than a certain threshold number of hours per day outdoors is needed to protect against 
myopia development – then our approach may have poorly captured the effects of the environmental exposures. 
For the combined meta-analysis of European and Asian cross-sectional studies, we assumed that each lead SNP 
tagged the underlying causal variant(s) equally well in European and Asian ancestry individuals, which is an over-
simplification. Finally, we chose to examine only a simple, binary GxE model, whereas more complex scenarios 
may exist40–42.
Conclusions
Specific myopia-predisposing SNPs were found to differ in the age at which they had their effects, and whether 
or not these effects got progressively stronger during later childhood. Thus, SNPs implicating the genes CHRNG, 
CACNA1D, LAMA2, CYP26A1 and BMP4 were associated with early onset changes in refractive error that did 
not progress further, while SNPs close to PRSS56, KCNQ5, TOX, ZIC2 and SHISA6 showed early-onset effects 
that became greater still at older ages. Effects that only appeared in later childhood – after the age of 7.5 years – 
implicated the genes CD55, CHD7, RORB, KCNMA1, A2BP1 and GJD2. Gene-environment interactions involv-
ing nearwork or time outdoors were rare or absent for the vast majority of the GWAS-identified SNPs, and indeed 
a genetic risk score that demonstrated very convincing association with early-onset (P = 2.2E–9) and later pro-
gressive (P = 5.8E–14) changes in refractive error appeared to act independently of the time children spent in 
these activities. However, one robust interaction between rs7829127 in ZMAT4 and time spent performing near-
work (nominal P = 6.3E–04, corrected P = 0.025) was observed, replicating a previously-identified interaction 
involving rs7829127 and years of education37,43,44.
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